moxifloxacin has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agbo, F; Blum, D; De Pandis, MF; Kleiman, R; Navia, B; Olanow, CW; Peckham, EL; Sciarappa, K; Stocchi, F | 1 |
| Andreas, JO; Braun, M; Cawello, W; Hnatkova, K; Hoeckendorff, J; Horstmann, R; Malik, M; Middle, M | 1 |
2 trial(s) available for moxifloxacin and Parkinson Disease
| Article | Year |
|---|---|
A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease.
Topics: Apomorphine; Double-Blind Method; Electrocardiography; Humans; Moxifloxacin; Parkinson Disease | 2022 |
Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Dopamine Agonists; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Parkinson Disease; Quinolines; Tetrahydronaphthalenes; Thiophenes | 2008 |